跳至主要内容
临床试验/NCT03154736
NCT03154736已完成不适用

Scaling-up Packages of Interventions for Cardiovascular Disease Prevention in Selected Sites in Europe and Sub-Saharan Africa: An Implementation Research

University Hospital, Brest23 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2017年10月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
56
试验地点
23
主要终点
Experiences of patients with cardiovascular disease

研究概览

简要总结

Cardiovascular disease is the leading cause of death in the world. 17.5 million people died in 2012 due to a cerebrovascular disease (31% of all causes of death). In Europe more than 50% of deaths are due to cardiovascular disease. The mortality rate for cardiovascular disease is higher in the lower socio-economic levels. Three-quarters of deaths from cardiovascular disease occur in developing countries. According to estimates in 2030, cardiovascular disease will be responsible for more deaths than the sum of infectious, nutritional, maternal and perinatal diseases in developing countries.

Measures to prevent cardiovascular risk factors have been shown to be effective.

The lack of an adequate primary care network in developing countries limits the screening and treatment of patients with cardiovascular risk factors. As a result, these patients do not benefit from adequate prevention, are diagnosed late and remain disabled or die at a young age, resulting in significant additional costs for families but also at the macroeconomic level.

Interventions are possible on a large scale (policies against tobacco and adverse dietary behavior, promote physical activity, etc.). Actions are possible on an individual level, both in primary prevention (control of cardiovascular risk factors) and secondary prevention, where many treatments have proved their effectiveness. These interventions are effective and cost-effective from a macroeconomic perspective. It was estimated that the cost of such interventions would not exceed 4% of health expenditure in developing countries and 1-2% in rich countries.

The World Health Organization insists on the importance of the triad composed by the patient and his family, community and health professionals. Results are possible only when these three components work together for the same purpose. Numerous studies show the benefit of the involvement of patients in their care in the rich countries and in the developing countries.

详细描述

This project builds on advances in the treatment of HIV / AIDS in Sub-Saharan Africa and in chronic disease management through the WHO Innovative Care for Chronic Conditions Framework.

These projects emerged from the observation that the rich country model of care (patient-centered, hospital-centered and specialist approach with regular clinical and paraclinic follow-up) was not transferable to developing countries, The limitation of human, technical and financial resources.

A paradigm shift is needed to improve cardiovascular disease control in a more cost-effective manner.

The SPICES project plans to integrate the current knowledge of new studies to improve the prevention and control of cardiovascular disease in high-, middle-, and low-income countries.

Rich countries and developing countries will therefore be involved in the study: the selected sites are France, the United Kingdom, Belgium, South Africa and Uganda.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Persons aged over 18 years.
  • Persons able to express their consent
  • Patients with FDRCV or CVD who gave written consent to participate in the study.
  • Family caregiver of patients with FDRCV or CVD with written consent to participate in the study

排除标准

  • Refusal to participate in the study
  • Patients and / or family caregiver who can not express their consent (illiterate, severe cognitive or psychiatric disorders)
  • Patients under judicial protection (guardianship and curatorship)
  • Pregnant women
  • Patients under 18 years of age

研究组 & 干预措施

Interview

Experimental

Individual interview an in a group interview. Socio-economic questionnaire

干预措施: Interview (Other)

结局指标

主要结局

Experiences of patients with cardiovascular disease

时间窗: 1 day

The representations on cardiovascular prevention and the follow-up experience of patients with cardiovascular disease or CVRF will be defined by questionnaire

次要结局

  • The obstacles of patients with cardiovascular disease(1 day)
  • Institutional care network(1 day)
  • Informal or informal care network(1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (23)

Loading locations...

相似试验

Scaling-up Packages of Interventions for... | 临床试验